108 related articles for article (PubMed ID: 6593320)
1. Processing of the formyl peptide receptor by HL-60 cells.
Anderson R; Niedel J
J Biol Chem; 1984 Nov; 259(21):13309-15. PubMed ID: 6593320
[TBL] [Abstract][Full Text] [Related]
2. Formyl peptide chemotactic receptor. Evidence for an active proteolytic fragment.
Dolmatch B; Niedel J
J Biol Chem; 1983 Jun; 258(12):7570-7. PubMed ID: 6305946
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the formyl peptide chemotactic receptor appearing at the phagocytic cell surface after exposure to phorbol myristate acetate.
Gardner JP; Melnick DA; Malech HL
J Immunol; 1986 Feb; 136(4):1400-5. PubMed ID: 3511145
[TBL] [Abstract][Full Text] [Related]
4. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
Jesaitis AJ; Naemura JR; Painter RG; Schmitt M; Sklar LA; Cochrane CG
J Cell Biochem; 1982; 20(2):177-91. PubMed ID: 6302115
[TBL] [Abstract][Full Text] [Related]
5. Asparagine-linked oligosaccharides on formyl peptide chemotactic receptors of human phagocytic cells.
Malech HL; Gardner JP; Heiman DF; Rosenzweig SA
J Biol Chem; 1985 Feb; 260(4):2509-14. PubMed ID: 3919002
[TBL] [Abstract][Full Text] [Related]
6. A subpopulation of cultured human promyelocytic leukemia cells (HL-60) displays the formyl peptide chemotactic receptor.
Niedel J; Kahane I; Lachman L; Cuatrecasas P
Proc Natl Acad Sci U S A; 1980 Feb; 77(2):1000-4. PubMed ID: 6928654
[TBL] [Abstract][Full Text] [Related]
7. Covalent affinity labeling of the formyl peptide chemotactic receptor.
Niedel J; Davis J; Cuatrecasas P
J Biol Chem; 1980 Aug; 255(15):7063-6. PubMed ID: 7391068
[TBL] [Abstract][Full Text] [Related]
8. The dynamics of ligand-receptor interactions. Real-time analyses of association, dissociation, and internalization of an N-formyl peptide and its receptors on the human neutrophil.
Sklar LA; Finney DA; Oades ZG; Jesaitis AJ; Painter RG; Cochrane CG
J Biol Chem; 1984 May; 259(9):5661-9. PubMed ID: 6715364
[TBL] [Abstract][Full Text] [Related]
9. N-formyl peptide receptors in human neutrophils display distinct membrane distribution and lateral mobility when labeled with agonist and antagonist.
Johansson B; Wymann MP; Holmgren-Peterson K; Magnusson KE
J Cell Biol; 1993 Jun; 121(6):1281-9. PubMed ID: 8509449
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of surface receptors for synthetic N-formylated chemotactic oligopeptides by stimulated peripheral blood neutrophils in psoriasis.
Glinski W; Anhalt T; Mansbridge JN
J Invest Dermatol; 1987 Nov; 89(5):523-8. PubMed ID: 3668297
[TBL] [Abstract][Full Text] [Related]
11. Covalent affinity labeling, detergent solubilization, and fluid-phase characterization of the rabbit neutrophil formyl peptide chemotaxis receptor.
Marasco WA; Becker KM; Feltner DE; Brown CS; Ward PA; Nairn R
Biochemistry; 1985 Apr; 24(9):2227-36. PubMed ID: 3995012
[TBL] [Abstract][Full Text] [Related]
12. Effects of tunicamycin on the expression and function of formyl peptide chemotactic receptors of differentiated HL-60 cells.
Heiman DF; Gardner JP; Apfeldorf WJ; Malech HL
J Immunol; 1986 Jun; 136(12):4623-30. PubMed ID: 3011898
[TBL] [Abstract][Full Text] [Related]
13. Identification of a human neutrophil protein of Mr 24 000 that binds N-formyl peptides: co-sedimentation with specific granules.
Allen RA; Erickson RW; Jesaitis AJ
Biochim Biophys Acta; 1989 Apr; 991(1):123-33. PubMed ID: 2653446
[TBL] [Abstract][Full Text] [Related]
14. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
Rotrosen D; Malech HL; Gallin JI
J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
[TBL] [Abstract][Full Text] [Related]
15. Detergent solubilization of the formyl peptide chemotactic receptor. Strategy based on covalent affinity labeling.
Niedel J
J Biol Chem; 1981 Sep; 256(17):9295-9. PubMed ID: 6267069
[TBL] [Abstract][Full Text] [Related]
16. Rat and human neutrophil N-formyl-peptide chemotactic receptors. Species difference in the glycosylation of similar 35-38 kDa polypeptide cores.
Remes JJ; Petäjä-Repo UE; Rajaniemi HJ
Biochem J; 1991 Jul; 277 ( Pt 1)(Pt 1):67-72. PubMed ID: 1854349
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of a bifunctional ligand of the formyl peptide receptor1 fused to the myc epitope.
Charest-Morin X; Roy C; Fernandes MJ; Marceau F
Int Immunopharmacol; 2015 Mar; 25(1):229-34. PubMed ID: 25681283
[TBL] [Abstract][Full Text] [Related]
18. Evidence for protonation in the human neutrophil formyl peptide receptor binding pocket.
Fay SP; Domalewski MD; Sklar LA
Biochemistry; 1993 Feb; 32(6):1627-31. PubMed ID: 8431442
[TBL] [Abstract][Full Text] [Related]
19. Dual Mg2+ control of formyl-peptide-receptor--G-protein interaction in HL 60 cells. Evidence that the low-agonist-affinity receptor interacts with and activates the G-protein.
Gierschik P; Steisslinger M; Sidiropoulos D; Herrmann E; Jakobs KH
Eur J Biochem; 1989 Jul; 183(1):97-105. PubMed ID: 2502402
[TBL] [Abstract][Full Text] [Related]
20. The formylpeptide chemoattractant receptor copurifies with a GTP-binding protein containing a distinct 40-kDa pertussis toxin substrate.
Polakis PG; Uhing RJ; Snyderman R
J Biol Chem; 1988 Apr; 263(10):4969-76. PubMed ID: 2832415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
